BC
Broadwood Capital Portfolio holdings
AUM
$1.53B
This Quarter Return
+21.79%
1 Year Return
+36.91%
3 Year Return
+67.63%
5 Year Return
+132.65%
10 Year Return
+697.91%
AUM
$584M
AUM Growth
+$584M
(+13%)
Cap. Flow
-$2.58M
Cap. Flow
% of AUM
-0.44%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
10
New
–
Increased
1
Reduced
–
Closed
1
Top Buys
| 1 |
IMDX
Insight Molecular Diagnostics Inc. Common Stock
IMDX
|
$7.75M |
Top Sells
| 1 |
IMPR
IMPRIVATA, INC COM
IMPR
|
$10.3M |
Sector Composition
| 1 | Healthcare | 42.88% |
| 2 | Consumer Staples | 40.17% |
| 3 | Technology | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Monster Beverage
MNST
$60.9B
| $235M | 40.17% | 1,599,136 | – | – |
|
2
STAAR Surgical
STAA
$1.36B
| $102M | 17.46% | 10,855,179 | – | – |
|
3
Lineage Cell Therapeutics
LCTX
$267M
| $97.1M | 16.61% | 24,897,032 | – | – |
|
4
iShares Russell 2000 ETF
IWM
$67B
| $52.2M | 8.93% | 420,000 | – | – |
|
|
CYNO
5
DELISTED
Cynosure, Inc. Class A
CYNO
| $46.7M | 7.99% | 916,975 | – | – |
|
|
MNK
6
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
| $22.5M | 3.85% | 322,411 | – | – |
|
|
AST
7
DELISTED
Asterias Biotherapeutics Inc. Series A
AST
| $15.7M | 2.68% | 3,699,848 | – | – |
|
|
IMDX
8
Insight Molecular Diagnostics Inc. Common Stock
IMDX
$72.4M
| $13.3M | 2.27% | 2,631,680 +1,538,461 | +141% | +$7.75M |
|
|
AST.WS
9
DELISTED
Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017)
AST.WS
| $171K | 0.03% | 328,205 | – | – |
|
|
IMPR
10
DELISTED
IMPRIVATA, INC COM
IMPR
| – | – | -737,911 | Closed | -$10.3M |
|